| Literature DB >> 26339609 |
Petra Lovecka1, Marketa Thimova1, Petra Grznarova1, Jan Lipov1, Zdenek Knejzlik1, Hana Stiborova1, Tjokorda Gde Tirta Nindhia2, Katerina Demnerova1, Tomas Ruml1.
Abstract
The benzonitrile herbicides bromoxynil, chloroxynil, dichlobenil, and ioxynil have been used actively worldwide to control weeds in agriculture since 1970s. Even though dichlobenil is prohibited in EU since 2008, studies addressing the fate of benzonitrile herbicides in the environment show that some metabolites of these herbicides are very persistent. We tested the cytotoxic effects of benzonitrile herbicides and their microbial metabolites using two human cell lines, Hep G2 and HEK293T, representing liver and kidneys as potential target organs in humans. The cell viability and proliferation were determined by MTT test and RTCA DP Analyzer system, respectively. The latter allows real-time monitoring of the effect of added substances. As the cytotoxic compounds could compromise cell membrane integrity, the lactate dehydrogenase test was performed as well. We observed high toxic effects of bromoxynil, chloroxynil, and ioxynil on both tested cell lines. In contrast, we determined only low inhibition of cell growth in presence of dichlobenil and microbial metabolites originating from the tested herbicides.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26339609 PMCID: PMC4538370 DOI: 10.1155/2015/381264
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Hydrolysis of dichlobenil, bromoxynil, chloroxynil, and ioxynil. The abbreviations are as follows: BAM: 2,6-dichlorobenzamide; 2,6-DCBA: 2,6-dichlorobenzoic acid; BrAM: 3,5-dibromo-4-hydroxy-benzamide; BrAC: 3,5-dibromo-4-hydroxybenzoic acid; IAM: 3,5-diiodo-4-hydroxybenzamide; and IAC: 3,5-diiodo-4-hydroxybenzoic acid. Degradation pathway utilizing enzyme nitrilase has not been previously observed for dichlobenil [3].
Figure 2The growth curves of Hep G2 cells in the presence of benzonitrile herbicides (100 mg/L). The arrow indicates the time of the application of tested compounds. Error bars are standard deviation of 3 parallels.
The inhibition coefficients I 24 (%) for 24 h exposure and I 48 (%) for 48 h exposure of benzonitrile pesticides and their microbial metabolic products on Hep G2 cells for concentrations 25 mg/L, 50 mg/L, and 100 mg/L.
| Compounds |
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| BRX | 20 ± 1 | 45 ± 3 | 52 ± 1 | 77 ± 2 | 92 ± 4 | 95 ± 3 |
| BRAC | 8 ± 0,4 | 11 ± 1 | 10 ± 1 | 10 ± 1 | 15 ± 1 | 20 ± 2 |
| BRAM | ND | ND | ND | 9 ± 0,5 | ND | 12 ± 2 |
| CHX | 50 ± 3 | 72 ± 2 | 70 ± 4 | 90 ± 2 | 90 ± 2 | 99 ± 1 |
| CHXAC | 10 ± 1 | 17 ± 2 | 25 ± 3 | 35 ± 2 | 50 ± 2 | 56 ± 3 |
| CHXAM | ND | 9 ± 1 | ND | 4 ± 0,1 | 10 ± 1 | 13 ± 1 |
| DCB | ND | ND | ND | 14 ± 1 | ND | 15 ± 2 |
| DCBA | ND | ND | ND | ND | 20 ± 2 | 12 ± 1 |
| BAM | ND | 3 ± 0,2 | ND | 4 ± 0,2 | 10 ± 1 | 13 ± 3 |
| IOX | 50 ± 3 | 58 ± 3 | 70 ± 4 | 88 ± 5 | 100 ± 5 | 100 ± 4 |
| IOXAC | ND | 3 ± 0,2 | ND | 10 ± 2 | ND | 19 ± 2 |
| IOXAM | ND | ND | ND | ND | ND | 16 ± 1 |
BRX: 3,5-dibromo-4-hydroxybenzonitrile, BRAC: 3,5-dibromo-4-hydroxybenzoic acid, BRAM: 3,5-dibromo-4-hydroxybenzamide, DCB: 2,6-dichlorobenzonitrile, DCBA: 2,6-dichlorobenzoic acid, BAM: 2,6-dichlorobenzamide, CHX: 3,5-dichloro-4-hydroxybenzonitrile, CHXAC: 3,5-dichloro-4-hydroxybenzoic acid, CHXAM: 3,5-dichloro-4-hydroxybenzamide, IOX: 3,5-diiodo-4-hydroxybenzonitrile, IOXAC: 3,5-diiodo-4-hydroxybenzoic acid, and IOXAM: 3,5-diiodo-4-hydroxybenzamide; ND: below detection limit; ∗: the solubility of DCB in water is around 20 mg/L; therefore the inhibitions at concentrations 50 and 100 mg/L are only indicative; ±: standard deviation of 3 parallels.
Figure 3The growth curves of HEK293T cells in the presence of benzonitrile herbicides (100 mg/L). The arrow indicates the time of the application of tested compounds. Error bars are standard deviation of 3 parallels.
The inhibition coefficient I 24 (%) for 24 h exposure and I 48 (%) for 48 h exposure for reflecting effect of benzonitrile pesticides on HEK293T cells for concentrations 25 mg/L, 50 mg/L, and 100 mg/L.
| Compounds |
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| BRX | 34 ± 1 | 38 ± 2 | 52 ± 2 | 59 ± 2 | 52 ± 2 | 62 ± 2 |
| CHX | 68 ± 2 | 70 ± 1 | 70 ± 3 | 83 ± 3 | 70 ± 1 | 82 ± 4 |
| IOX | 48 ± 1 | 54 ± 2 | 59 ± 2 | 62 ± 3 | 59 ± 2 | 75 ± 3 |
| DCB | ND | ND | ND | ND | ND | ND |
BRX: 3,5-dibromo-4-hydroxybenzonitrile, CHX: 3,5-dichloro-4-hydroxybenzonitrile, IOX: 3,5-diiodo-4-hydroxybenzonitrile, and DCB: 2,6-dichlorobenzonitrile; ND: cytotoxicity not observed; ∗: the solubility of DCB in water is around 20 mg/L; therefore the inhibitions at concentrations 50 and 100 mg/L are only indicative; ±: standard deviation of 3 parallels.
The inhibition coefficient I (%) determined by the MTT test for Hep G2 and HEK293T cells for 25, 50, and 100 mg/L. The HEK293T cells were exposed for 24 h and Hep G2 cells for 48 h.
|
| Hep G2 | HEK293T | |
|---|---|---|---|
|
|
| ||
| BRX | 100 | 91 ± 1 | 53 ± 2 |
| 50 | 71 ± 1 | 25 ± 1 | |
| 25 | 28 ± 1 | 13 ± 3 | |
|
| |||
| BRAC | 100 | 13 ± 3 | 7 ± 1 |
| 50 | 15 ± 5 | 7 ± 1 | |
| 25 | 15 ± 7 | 10 ± 5 | |
|
| |||
| BRAM | 100 | 17 ± 6 | 14 ± 1 |
| 50 | 16 ± 3 | 12 ± 2 | |
| 25 | 8 ± 2 | 11 ± 4 | |
|
| |||
| DCB | 100 | 9 ± 6 | 4 ± 4 |
| 50 | 16 ± 8 | 9 ± 5 | |
| 25 | 21 ± 6 | 13 ± 7 | |
|
| |||
| DCBA | 100 | 19 ± 4 | 10 ± 5 |
| 50 | 21 ± 7 | 13 ± 5 | |
| 25 | 22 ± 3 | 9 ± 1 | |
|
| |||
| BAM | 100 | 22 ± 5 | 12 ± 2 |
| 50 | 20 ± 1 | 16 ± 2 | |
| 25 | 14 ± 4 | 14 ± 6 | |
|
| |||
| CHX | 100 | 91 ± 1 | 39 ± 2 |
| 50 | 74 ± 1 | 22 ± 4 | |
| 25 | 21 ± 3 | 19 ± 7 | |
|
| |||
| CHXAC | 100 | 16 ± 6 | 18 ± 6 |
| 50 | 17 ± 7 | 18 ± 7 | |
| 25 | 15 ± 4 | 19 ± 7 | |
|
| |||
| CHXAM | 100 | 17 ± 7 | 22 ± 5 |
| 50 | 19 ± 3 | 24 ± 4 | |
| 25 | 13 ± 2 | 16 ± 4 | |
|
| |||
| IOX | 100 | 98 ± 1 | 61 ± 2 |
| 50 | 87 ± 1 | 41 ± 6 | |
| 25 | 82 ± 3 | 22 ± 4 | |
|
| |||
| IOXAC | 100 | 13 ± 7 | 14 ± 2 |
| 50 | 13 ± 3 | 15 ± 2 | |
| 25 | 15 ± 6 | 18 ± 2 | |
|
| |||
| IOXAM | 100 | 21 ± 4 | 25 ± 4 |
| 50 | 19 ± 3 | 19 ± 6 | |
| 25 | 11 ± 2 | 18 ± 4 | |
BRX: 3,5-dibromo-4-hydroxybenzonitrile, BRAC: 3,5-dibromo-4-hydroxybenzoic acid, BRAM: 3,5-dibromo-4-hydroxybenzamide, DCB: 2,6-dichlorobenzonitrile, DCBA: 2,6-dichlorobenzoic acid, BAM: 2,6-dichlorobenzamide, CHX: 3,5-dichloro-4-hydroxybenzonitrile, CHXAC: 3,5-dichloro-4-hydroxybenzoic acid, CHXAM: 3,5-dichloro-4-hydroxybenzamide, IOX: 3,5-diiodo-4-hydroxybenzonitrile, IOXAC: 3,5-diiodo-4-hydroxybenzoic acid, and IOXAM: 3,5-diiodo-4-hydroxybenzamide; SD: standard deviation of 3 parallel measurements; ∗: the solubility of DCB in water is around 20 mg/L; therefore the inhibitions at concentrations 50 and 100 mg/L are only indicative; ±: standard deviation of 3 parallels.
The mortality values (%) of Hep G2 cells determined by the LDH for concentration 25, 50, and 100 mg/L after 48 h.
| 100 mg/L | 50 mg/L | 25 mg/L | |
|---|---|---|---|
| BRX | 31 ± 9 | 5 ± 3 | 2 ± 1 |
| CHX | 48 ± 10 | 33 ± 9 | 5 ± 3 |
| IOX | 43 ± 12 | 22 ± 8 | 1 ± 2 |
| DCB | ND | ND | ND |
BRX: bromoxynil, CHX: chloroxynil, IOX: ioxynil, and DCB: 2,6-dichlorobenzonitrile; ND: cytotoxicity not observed; ±: standard deviation of 3 parallels.